[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"patient-satisfaction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:patient-satisfaction":27},{"pageToken":4,"total":5,"offset":6,"count":7,"results":8},null,47,0,25,[9,51,85,117,144,170,199,227,251,278,308,343,370,396,428,457,479,504,533,562,588,614,640,665,687],{"id":10,"slug":11,"hasResults":12,"nctId":13,"briefTitle":14,"officialTitle":15,"acronym":4,"eligibilityCriteria":16,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100054130","rutiss-diary-and-rutiss-65-study-100054130",false,"NCT07698041","RUTISS-Diary and RUTISS-65 Study","Developing and Validating Two New Patient-Reported Outcome Measures of Recurrent Urinary Tract Infection Symptoms: A Symptoms Diary and Adapted Measure for Older Adults","Inclusion for RUTISS-Diary:\n\n* Participants must be 18 years and older\n* All participants must have native\u002Fbilingual or advanced fluency in English.\n* Access to a computer\u002Fmobile device for survey completion.\n* Symptoms-led diagnosis: Participants must report that they experience recurrent UTI episodes or symptoms. They must report the minimum of 2 UTIs in 6 months or 3 in 12 months, in line with the rUTI diagnostic criteria (European Association of Urology, 2020).\n\nInclusion for RUTISS- 65:\n\n* Participants must be 65 years and older\n* Access to a computer\u002Fmobile device for survey completion, paper copy available upon request.\n* All participants must have native\u002Fbilingual or advanced fluency in English.\n* Symptoms-led diagnosis: Participants must report that they experience recurrent UTI episodes or symptoms. They must report the minimum of 2 UTIs in 6 months or 3 in 12 months, in line with the rUTI diagnostic criteria (European Association of Urology, 2020).\n\nExclusion criteria (for RUTISS-Diary and RUTISS-65)\n\n* Participants must not report a current diagnosis of interstitial cystitis (measured in demographics questionnaire).\n* Symptoms of cognitive confusion or dementia.\n* No active malignancy e.g. bladder or prostate cancer\n* Participants must not report beginner or intermediate level fluency in English. Future work will be done to translate the PROMs into alternative languages.\n* In addition to the interstitial cystitis exclusion question, participants will also be asked in the demographic questionnaire if they are pregnant or have an indwelling catheter or use intermittent self-catheterisation. Participants who report \"yes\" to either of these will be excluded from participation.","ALL","18 Years",{"count":20,"type":21},200,"ESTIMATED","OBSERVATIONAL","Existing patient-reported outcome measures assess acute urinary tract infection but do not support daily symptom tracking in recurrent UTI (rUTI) or meet the needs of older adults. This single-site study will develop and validate two adapted measures: the RUTISS-Diary for daily symptom monitoring and the RUTISS-65 for reporting symptoms in adults aged 65 years and over. Approximately 200 participants with rUTI will complete the RUTISS-Diary daily for 7 days and again on day 14. Participants aged 65 years and over will also complete the RUTISS-65 on days 1 and 2 to assess its reliability and validity.",[25,26,27,28],"Urology","Urological Diseases","Patient Satisfaction","Pain, Chronic",[30,31,32,33,34,35,36,37],"recurrent urinary tract infection","rUTI","outcome measure","PROMs","urinary","UTI","burden","assessment tools","NOT_YET_RECRUITING","2026-07-06",{"date":41,"type":42},"2026-07-13","ACTUAL",{"date":44,"type":21},"2026-07-08",{"date":46,"type":21},"2027-12-24",{"name":48,"class":49},"Katherine Finlay","OTHER",2,{"id":52,"slug":53,"hasResults":12,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":4,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":18,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":71,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":4},"100639382","the-impact-of-ai-powered-training-on-gynecological-examination-anxiety-and-satisfaction-100639382","NCT07599358","The Impact of AI-Powered Training on Gynecological Examination Anxiety and Satisfaction","Digital Transformation in Women's Health: The Impact of AI-Powered Training on Gynecological Examination Anxiety and Satisfaction","Inclusion Criteria:\n\n* Applying to the outpatient clinic for a gynecological examination\n* Being between 18-65 years of age\n* Agreeing to participate in the study\n\nExclusion Criteria:\n\n* Communication barrier\n* Having a psychological diagnosis,\n* Being pregnant",true,"FEMALE","65 Years",{"count":62,"type":21},114,"INTERVENTIONAL",[65],"NA","Gynecological cancers, particularly cervical, ovarian, and endometrial cancers, pose a global problem. Cervical cancers are quite common worldwide, and this rate is even higher in developing countries. Cervical cancers are easily treatable when detected early, and screening is quite easy. Diagnosis is routinely made through human papillomavirus (HPV) testing and cytological screening. Eliminating anxiety, fear, and uncertainty about gynecological examinations makes the examination process easier, thus enabling early diagnosis and treatment of diseases. Keeping up with developing and changing technology and using it to improve women's health is an undeniable change in recent times. This study aims to determine the effect of an AI-assisted informational training program on women's anxiety and satisfaction levels regarding gynecological examinations.",[68,69,27,70],"Gynecological Examination","Artificial Intelligence (AI)","Anxiety",[72,73,74,75],"gynecological examination","artificial intelligence","patient satisfaction","anxiety","2026-05-14",{"date":78,"type":42},"2026-05-20",{"date":80,"type":21},"2026-05-02",{"date":82,"type":21},"2026-09-29",{"name":84,"class":49},"Fenerbahce University",{"id":86,"slug":87,"hasResults":12,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":4,"eligibilityCriteria":91,"healthyVolunteers":58,"sex":59,"minAge":18,"maxAge":4,"enrollmentInfo":92,"targetDuration":4,"studyType":63,"phases":94,"briefSummary":95,"conditions":96,"keywords":98,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":116},"100590568","music-use-in-parturients-admitted-to-labor--delivery-100590568","NCT06969105","Music Use in Parturients Admitted to Labor & Delivery","A Randomized Controlled Trial of Music Use in Parturients Admitted to Labor & Delivery","Inclusion Criteria:\n\n* Age: 18 years or older\n* Laboring parturients or those scheduled for an induction of labor\n* Able to provide informed consent\n* American Society of Anesthesiologists (ASA) physical status rating of II-III\n\nExclusion Criteria:\n\n* Patient refusal\n* Impaired hearing\n* Patient is taking at least one anxiolytic medication daily at baseline\n* Intrauterine fetal demise\n* Severe psychiatric disorder",{"count":93,"type":21},106,[65],"The goal of this clinical trial is to learn if music use affects anxiety or pain levels in parturients admitted to labor and delivery. It will also learn about the effect of music use on patient satisfaction. The main questions it aims to answer are:\n\nDoes music use affect anxiety levels in parturients admitted to labor and delivery? Does music use affect pain levels in parturients admitted to labor and delivery? Does music use affect patient satisfaction in parturients admitted to labor and delivery?\n\nResearchers will compare music to a control (no music) to see if music affects anxiety levels in parturients admitted to labor and delivery.\n\nParticipants will:\n\nListen to music or listen to no music for a 10 minute duration in the labor and delivery unit.\n\nAnswer questions about anxiety and pain levels at a few different timepoints. Have information collected from medical charts (vital signs and cervical dilation).\n\nRate their satisfaction with care.",[70,97,27],"Pain",[99,100,101,75,102,103,104,105],"music","labor and delivery","parturients","analgesia","anesthesia","pain","epidural","RECRUITING","2026-04-30",{"date":109,"type":42},"2026-05-01",{"date":111,"type":42},"2025-05-30",{"date":113,"type":21},"2027-05",{"name":115,"class":49},"Tufts Medical Center",1,{"id":118,"slug":119,"hasResults":12,"nctId":120,"briefTitle":121,"officialTitle":122,"acronym":4,"eligibilityCriteria":123,"healthyVolunteers":12,"sex":17,"minAge":124,"maxAge":4,"enrollmentInfo":125,"targetDuration":4,"studyType":63,"phases":127,"briefSummary":128,"conditions":129,"keywords":131,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":4},"100624941","reducing-waiting-time-for-vision-refraction-services-100624941","NCT07416175","Reducing Waiting Time for Vision Refraction Services","Reducing Waiting Time for Vision Refraction Services in an Eye Care OPD: an Operational Research Study","Inclusion Criteria: All patients awaiting vision refraction services. -\n\nExclusion Criteria: Patients aged less than 19 years.\n\n\\-","19 Years",{"count":126,"type":21},350,[65],"The Out-Patient Departments (OPD) is often the first point of contact for patients seeking healthcare services and involves the coordination of both administrative and clinical processes. High patient volume and inefficient patient flow can result in prolonged waiting time, contributing to patient dissatisfaction. We performed a root cause analysis (RCA) through group interviews with OPD patients visiting Geta Eye Hospital, Nepal to understand the factors contributing to dissatisfaction towards OPD waiting time. In addition, patient flow through OPD service points was mapped, time-in, time-out and waiting time across OPD rooms was recorded to identify operational bottlenecks for intervention.\n\nThe Vision Refraction room (VRR) emerged as key contributor to prolonged waiting time. This operational research study aims to determine the reasons for delay in the VRR and develop strategies to reduce the mean waiting time and improve patient satisfaction with waiting time. This study will be conducted over a 6-8 month period using a two-phase before and after intervention design. Phase 1 will establish baseline waiting time and patient satisfaction, and identify operational challenges. Based on these findings, context-specific interventions will be developed and implemented in Phase 2, and waiting time and patient satisfaction will be reassessed.",[27,130],"Waiting Times, Patient Pathways, Effect of Lifestyle-related, Clinical and Demographic Parameters on Outcomes",[132,133,134,135],"Waiting time","Patient satisfaction","Operational research","Quality improvement","2026-04-29",{"date":107,"type":42},{"date":139,"type":21},"2026-06",{"date":141,"type":21},"2026-12",{"name":143,"class":49},"Seva Canada Society",{"id":145,"slug":146,"hasResults":12,"nctId":147,"briefTitle":148,"officialTitle":149,"acronym":4,"eligibilityCriteria":150,"healthyVolunteers":58,"sex":17,"minAge":18,"maxAge":60,"enrollmentInfo":151,"targetDuration":4,"studyType":63,"phases":152,"briefSummary":153,"conditions":154,"keywords":156,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":161,"lastUpdatePostDateStruct":162,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":168,"locationsCount":116},"100636272","early-oral-hydration-in-relieving-postoperative-thirst-100636272","NCT07563530","Early Oral Hydration in Relieving Postoperative Thirst","Effectiveness of Early Oral Hydration in Relieving Postoperative Thirst in Patients Undergoing Urological Endoscopic Procedures: A Randomized Controlled Trial","Inclusion Criteria:\n\n1. Male and female patients aged 18-65 years.\n2. Scheduled for elective urological endoscopic procedures under general anesthesia.\n3. Day-care endoscopic procedures.\n4. ASA classification I-III.\n\nExclusion Criteria:\n\n1. Known gastrointestinal disorders contraindicating early oral hydration (e.g., peptic ulcer disease, hiatal hernia, irritable bowel syndrome, esophagitis, or prior gastrointestinal surgery).\n2. Inability to express thirst or communicate (e.g., language barrier, altered consciousness).\n3. Requirement for nasogastric suction.\n4. History of facial, oropharyngeal, or laryngeal surgery.\n5. Swallowing dysfunction or delayed gastric emptying (e.g., gastroparesis).\n6. Incomplete reversal of muscle relaxant at PACU admission (no adequate spontaneous breathing or protective airway reflexes).",{"count":20,"type":21},[65],"This study aims to evaluate whether allowing early oral hydration on demand effectively relieves postoperative thirst and enhances patient satisfaction in individuals undergoing urological endoscopic procedures",[155,27],"Thirst; Due to Deprivation of Water",[157,158,159,160],"Postoperative","Thirst","Oral Hydration","Satisfaction","2026-04-25",{"date":163,"type":42},"2026-05-04",{"date":165,"type":42},"2026-04-18",{"date":167,"type":21},"2026-10-18",{"name":169,"class":49},"Sindh Institute of Urology and Transplantation",{"id":171,"slug":172,"hasResults":12,"nctId":173,"briefTitle":174,"officialTitle":175,"acronym":176,"eligibilityCriteria":177,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":178,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":180,"conditions":181,"keywords":184,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":191,"lastUpdatePostDateStruct":192,"startDateStruct":193,"completionDateStruct":195,"leadSponsor":197,"locationsCount":116},"100636033","patient-satisfaction-following-multidisciplinary-cancer-care-assessment-in-day-hospital-a-prospective-observational-study-100636033","NCT07560423","Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital: A Prospective Observational Study.","Evaluation and Analysis of Patient Satisfaction Following Multidisciplinary Complex Assessment in Day Hospital: Determinants and Implications for Continuous Quality Improvement","EVAQSAP-HDJ-BC","Inclusion Criteria:\n\n* Adult patients (≥ 18 years old)\n* Patients undergoing a multidisciplinary \"complex assessment\" in a Day Hospital setting\n* Patients diagnosed with cancer and scheduled to receive injectable anticancer treatment\n* Ability to understand and complete the satisfaction questionnaire\n* Patients who have been informed and have not opposed participation\n\nExclusion Criteria:\n\n* Patients under 18 years of age\n* Patients unable to complete the questionnaire (e.g., severe cognitive impairment or major language barrier)\n* Patients who refuse participation\n* Patients with incomplete Day Hospital complex assessment\n* Patients under legal protection (guardianship or curatorship)\n\nPatients under legal protection (guardianship or curatorship)",{"count":179,"type":21},309,"This study aims to evaluate patient satisfaction following a multidisciplinary \"complex assessment\" conducted in a Day Hospital setting at the Centre Hospitalier de Martigues. This assessment is part of routine care for patients diagnosed with cancer and scheduled to receive injectable anticancer treatment.\n\nDuring this assessment, patients meet several healthcare professionals, including a pharmacist, dietitian, psychologist, social worker, and supportive care providers. The objective is to identify patient-specific needs and improve coordination of care at an early stage of the treatment pathway.\n\nThis is a prospective observational study based on an anonymous satisfaction questionnaire distributed to eligible adult patients after completion of the Day Hospital assessment. The primary objective is to assess overall patient satisfaction. Secondary objectives include evaluating satisfaction by specialty, identifying factors associated with satisfaction, and assessing the Net Promoter Score (NPS).\n\nThe results of this study are expected to help identify strengths and areas for improvement in multidisciplinary care, enhance patient-centered care, and support continuous quality improvement in oncology practice.",[27,182,183],"Cancer","Quality of Health Care",[185,186,187,188,189,190],"Multidisciplinary Care","Oncology","Supportive Care","Patient Experience","Health Services Research","Net Promoter Score","2026-04-24",{"date":109,"type":42},{"date":194,"type":42},"2025-07-10",{"date":196,"type":21},"2029-04-15",{"name":198,"class":49},"Centre Hospitalier de Martigues",{"id":200,"slug":201,"hasResults":12,"nctId":202,"briefTitle":203,"officialTitle":204,"acronym":205,"eligibilityCriteria":206,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":207,"targetDuration":209,"studyType":22,"phases":4,"briefSummary":210,"conditions":211,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":218,"lastUpdatePostDateStruct":219,"startDateStruct":221,"completionDateStruct":223,"leadSponsor":225,"locationsCount":4},"100617607","quality-of-life-and-functional-outcomes-in-laryngeal-cancer-patients-100617607","NCT07320820","Quality of Life and Functional Outcomes in Laryngeal Cancer Patients","Assessment of Quality of Life, Patient Satisfaction, Swallowing Function, Voice Outcomes, Pain, and Anxiety-Depression at Baseline and at 3-, 6-, and 12-Month Follow-Up in Patients Diagnosed With Laryngeal Squamous Cell Carcinoma: A Prospective Questionnaire-Based Study","QoL in LSSC","Inclusion Criteria:\n\n* Age ≥ 18 years at the time of enrollment.\n* Histopathologically confirmed diagnosis of laryngeal squamous cell carcinoma.\n* Planned to undergo surgical treatment or radiotherapy\u002Fchemoradiotherapy as part of standard oncological care.\n* Willing and able to participate in the study and to provide written informed consent.\n* No history of psychiatric or neurological disorders that could impair comprehension, questionnaire completion, or study participation.\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years.\n* Presence of comorbid conditions that may independently affect swallowing or voice functions.\n* Patients who withdraw consent or request to discontinue participation during or after the treatment period.\n* History of psychiatric disorders or use of psychiatric medications that may interfere with study participation or completion of patient-reported outcome measures.",{"count":208,"type":21},120,"12 Months","Laryngeal squamous cell carcinomas are head and neck malignancies that directly affect both swallowing and voice functions and are associated with a significant deterioration in patients' quality of life throughout the treatment process.\n\nThe aim of this study is to evaluate quality of life, voice and swallowing functions, pain, anxiety-depression levels, and patient satisfaction at the pre-treatment period and at the 3rd, 6th, and 12th months post-treatment in patients with laryngeal malignancies, using validated questionnaires, in order to:\n\nElucidate the course of functional recovery following treatment,\n\nIndividualize rehabilitation and follow-up strategies, and\n\nExamine the relationship between functional outcomes and oncological survival.",[212,213,27,214,215,216,217],"Laryngeal Carcinoma","Quality of Life (QOL)","Voice Quality","Swallowing Function","Pain Management","Anxiety Depression","2026-04-21",{"date":220,"type":42},"2026-04-22",{"date":222,"type":21},"2026-04-02",{"date":224,"type":21},"2027-12-31",{"name":226,"class":49},"Saglik Bilimleri Universitesi",{"id":228,"slug":229,"hasResults":12,"nctId":230,"briefTitle":231,"officialTitle":232,"acronym":4,"eligibilityCriteria":233,"healthyVolunteers":12,"sex":234,"minAge":18,"maxAge":4,"enrollmentInfo":235,"targetDuration":4,"studyType":63,"phases":236,"briefSummary":237,"conditions":238,"keywords":4,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":241,"lastUpdatePostDateStruct":242,"startDateStruct":244,"completionDateStruct":246,"leadSponsor":248,"locationsCount":250},"100591023","educational-discharge-video-impact-on-post-operative-healthcare-utilization-after-holep-100591023","NCT06975033","Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP","The Impact of Discharge Educational Discharge Videos on Post-Operative Care Utilization After Holmium Laser Enucleation of the Prostate (HoLEP) Procedures","Inclusion Criteria:\n\n1. Adults aged 18+\n2. Patients scheduled for a HoLEP procedure\n3. Patients willing to complete both baseline and follow up surveys\n4. Patients able to provide informed consent\n5. Patients are English-speaking and understand English\n\nExclusion Criteria:\n\n1. Patients under 18+\n2. Patients unable to consent\n3. Patients unable to complete surveys\n4. Patients without a prostate.\n5. Patients are non-English speakers","MALE",{"count":62,"type":21},[65],"This will be a randomized interventional study. Patients scheduled to undergo a HoLEP at UCSF will be randomized into two groups after the procedure: one group will watch a scripted educational HoLEP video and the other group will not receive a video. We will monitor the post-operative care utilization after discharge. Secondary outcomes will include patient satisfaction.",[239,27,240],"HoLEP","Educational Video Intervention","2026-04-13",{"date":243,"type":42},"2026-04-16",{"date":245,"type":42},"2025-11-04",{"date":247,"type":21},"2026-12-01",{"name":249,"class":49},"University of California, San Francisco",3,{"id":252,"slug":253,"hasResults":12,"nctId":254,"briefTitle":255,"officialTitle":256,"acronym":4,"eligibilityCriteria":257,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":258,"targetDuration":4,"studyType":63,"phases":260,"briefSummary":261,"conditions":262,"keywords":266,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":270,"lastUpdatePostDateStruct":271,"startDateStruct":272,"completionDateStruct":274,"leadSponsor":276,"locationsCount":116},"100632764","chewing-gum-and-cold-gargle-on-post-bronchoscopy-symptoms-100632764","NCT07517926","Chewing Gum and Cold Gargle on Post-Bronchoscopy Symptoms","The Effect of Chewing Gum and Gargling With Cold Water on Post-Bronchoscopy Sore Throat, Dysphagia, and Patient Satisfaction: A Randomized Controlled Study","Inclusion Criteria:\n\n* • Being 18 years of age or older\n\n  * Having a scheduled diagnostic bronchoscopy\n  * Having normal speech and swallowing functions\n  * Being conscious and able to communicate\n  * Volunteering to participate in the study\n\nExclusion Criteria:\n\n* • Complications during bronchoscopy\n\n  * Gastroesophageal reflux\n  * Use of non-steroidal anti-inflammatory drugs\n  * Receiving steroid treatment within 1 week prior to the procedure\n  * Active infection or disease in the mouth or throat area\n  * History of allergy or intolerance to the procedure\n  * Previous anatomical or functional impediment to chewing gum or gargling",{"count":259,"type":21},100,[65],"This study aims to evaluate the effects of chewing gum and gargling with cold water on common post-bronchoscopy symptoms, such as sore throat and difficulty swallowing (dysphagia). Bronchoscopy is a procedure that can cause temporary throat discomfort. In this randomized controlled trial, patients will be divided into groups to receive either chewing gum, cold water gargle, or standard care. The researchers will then measure and compare patient satisfaction levels and the severity of throat symptoms to determine if these simple interventions can improve patient comfort after the procedure.",[263,264,27,265],"Sore Throat","Dysphagia","Bronchoscopy",[265,263,264,267,268,269],"Chewing Gum","Cold Water Gargle","Nursing Care","2026-04-07",{"date":241,"type":42},{"date":273,"type":42},"2025-11-10",{"date":275,"type":21},"2026-05-11",{"name":277,"class":49},"Ankara University",{"id":279,"slug":280,"hasResults":12,"nctId":281,"briefTitle":282,"officialTitle":283,"acronym":284,"eligibilityCriteria":285,"healthyVolunteers":58,"sex":17,"minAge":18,"maxAge":60,"enrollmentInfo":286,"targetDuration":4,"studyType":63,"phases":288,"briefSummary":289,"conditions":290,"keywords":295,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":299,"lastUpdatePostDateStruct":300,"startDateStruct":302,"completionDateStruct":304,"leadSponsor":306,"locationsCount":116},"100631362","traction-pressure-and-rapid-muscle-release-tpr-technique-during-intramuscular-injection-effects-on-pain-and-patient-satisfaction-100631362","NCT07499687","Traction, Pressure, and Rapid Muscle Release (TPR) Technique During Intramuscular Injection: Effects on Pain and Patient Satisfaction","The Effect of the Traction, Pressure, and Rapid Muscle Release (TPR) Technique on Pain and PatientSatisfaction During Intramuscular Injection: A Randomized Controlled Experimental Study","TPRTDIMI","Inclusion Criteria:\n\n* Voluntary participation in the study\n* Ability to speak and understand Turkish\n* Being between 18 and 65 years of age\n* Having a body mass index (BMI) between 18.5 and 30\n* No sensory impairment in the ventrogluteal muscles\n\nExclusion Criteria:\n\n* Presence of a scar, burn, redness, hematoma, bruising, tenderness, or induration at the injection site\n* History of intramuscular injection in the ventrogluteal region within the last 15 days\n* Presence of injection-related fear\n* Diagnosis of Diabetes Mellitus\n* History of neuropathy\n* Presence of any hearing, visual, or speech impairment\n* Presence of a mental disability\n* Use of oral or parenteral analgesic medication before the procedure.",{"count":287,"type":21},102,[65],"This study will be conducted to evaluate the effect of the Traction, Pressure, and Rapid Muscle Release (TPR) technique, an innovative method used during intramuscular vitamin B12 (cyanocobalamin) injections, on patients' pain and satisfaction levels compared with the conventional injection method.",[291,292,293,27,294],"Injection Techniques","Nursing Interventions","Injection Pain Prevention","Intramuscular Injection",[296,297,104,298],"intramuscular injection","tpr technique","satisfaction","2026-03-24",{"date":301,"type":42},"2026-03-30",{"date":303,"type":21},"2026-04-06",{"date":305,"type":21},"2026-10",{"name":307,"class":49},"Bezmialem Vakif University",{"id":309,"slug":310,"hasResults":12,"nctId":311,"briefTitle":312,"officialTitle":313,"acronym":314,"eligibilityCriteria":315,"healthyVolunteers":12,"sex":17,"minAge":316,"maxAge":4,"enrollmentInfo":317,"targetDuration":4,"studyType":63,"phases":319,"briefSummary":320,"conditions":321,"keywords":331,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":334,"lastUpdatePostDateStruct":335,"startDateStruct":336,"completionDateStruct":338,"leadSponsor":340,"locationsCount":342},"100510689","evaluating-novel-healthcare-approaches-to-nurturing-and-caring-for-hospitalized-elders-100510689","NCT05929703","Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders","Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders (ENHANCE)","ENHANCE","Inclusion Criteria:\n\n* Provision of informed consent\n* At least 70 years of age\n* Anticipated length of hospital stay at least 72 hours\n* Family member or care partner available to be on-site in the hospital\n* At least one delirium risk factor (e.g., cognitive or functional impairment, dehydration, vision or hearing impairment)\n* Evaluable cognitive function at baseline (i.e., ability to complete baseline cognitive function assessment)\n\nExclusion Criteria:\n\n* Delirium on admission\n* Unable to communicate verbally (e.g., coma, mechanical ventilation)\n* Unable to participate fully in interventions (e.g., terminal condition, advanced dementia)\n* Staff safety concerns (e.g., violent behavior)\n* Cardiac or intracranial surgery (due to competing causes of delirium)","70 Years",{"count":318,"type":21},1900,[65],"The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following:\n\n1. To compare the effectiveness of FAM-HELP and HELP in reducing both the incidence of delirium and its severity.\n2. To compare the effectiveness of FAM-HELP and HELP in improving patient- and family-reported outcomes.\n3. To explore the implementation context, process, and outcomes of the FAM-HELP program in diverse hospital settings.",[322,323,324,325,326,327,328,329,330,27],"Delirium","Neurocognitive Disorders","Mild Cognitive Impairment","Alzheimer Disease","Aging","Family Support","Family Members","Caregiver Burden","Implementation Science",[322,332,333,330],"Clinical Trial","Comparative Effectiveness Research","2026-03-20",{"date":299,"type":42},{"date":337,"type":42},"2023-12-04",{"date":339,"type":21},"2027-08",{"name":341,"class":49},"University of Michigan",7,{"id":344,"slug":345,"hasResults":12,"nctId":346,"briefTitle":347,"officialTitle":348,"acronym":349,"eligibilityCriteria":350,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":351,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":353,"conditions":354,"keywords":358,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":361,"lastUpdatePostDateStruct":362,"startDateStruct":364,"completionDateStruct":366,"leadSponsor":368,"locationsCount":116},"100629200","patient-satisfaction-study-at-aou-maggiore-della-carit-score-100629200","NCT07471581","Patient Satisfaction Study at AOU Maggiore Della Carità (SCORE)","Patient Satisfaction With Care: A Cross-Sectional Observational Study at AOU Maggiore Della Carità, Novara (SCORE)","SCORE","Inclusion Criteria:\n\n* Adult inpatients (age ≥ 18 years) admitted to ordinary wards of AOU Maggiore della Carità.\n* Hospitalization for at least 48 hours at the time of questionnaire administration.\n* Able to provide informed consent.\n* Able to understand and speak Italian.\n\nExclusion Criteria:\n\n* Hospitalization shorter than 48 hours.\n* Age \\\u003C 18 years.\n* Cognitive impairment or clinical conditions preventing comprehension or autonomous completion of the questionnaire.\n* Refusal or inability to provide informed consent.",{"count":352,"type":21},250,"The general aim of this study is to assess and analyze the level of patient satisfaction with nursing care among inpatients in the ordinary wards of the AOU Maggiore della Carità in Novara (Italy). Using the validated Newcastle Satisfaction with Nursing Scales (NSNS), the study intends to produce reliable and comparable data that reflect patients' perceived quality of care across multiple dimensions, including relationships, emotional support, information, and time devoted by nurses. The study aims to provide an updated overview of patient experiences, identifying strengths and areas for improvement. These results will offer guidance for organizational and educational strategies to promote more personalized, human-centered nursing care aligned with international quality and safety recommendations, without altering routine clinical practice.",[27,355,269,356,357],"Nursing","Patient-Centered Care","Cross-Sectional Studies",[27,355,269,356,359,360,188],"Cross-Sectional Study","Healthcare Quality","2026-03-10",{"date":363,"type":42},"2026-03-13",{"date":365,"type":21},"2026-04-09",{"date":367,"type":21},"2026-05-31",{"name":369,"class":49},"Università degli Studi del Piemonte Orientale Amedeo Avogadro",{"id":371,"slug":372,"hasResults":12,"nctId":373,"briefTitle":374,"officialTitle":375,"acronym":376,"eligibilityCriteria":377,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":378,"targetDuration":4,"studyType":63,"phases":380,"briefSummary":381,"conditions":382,"keywords":4,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":387,"lastUpdatePostDateStruct":388,"startDateStruct":390,"completionDateStruct":392,"leadSponsor":394,"locationsCount":116},"100628625","advanced-brain-imaging-tka-fmri-tka-100628625","NCT07464080","Advanced Brain Imaging-TKA (fMRI-TKA)","Brain Network-based Precision Medicine to Predict Dissatisfaction Following Total Knee Arthroplasty","fMRI-TKA","Inclusion Criteria:\n\n1. Male and female patients aged 18 years or older\n2. Primary TKA\n3. Diagnosis of osteoarthritis, inflammatory arthritis, or osteonecrosis\n\nExclusion Criteria:\n\n1. Inability or refusal to sign informed consent form\n2. Non-English or French speaking, and no licensed translator, family member or substitute decision maker available\n3. History of major neurological disorders (e.g traumatic brain injury, epilepsy, multiple sclerosis\n4. Cognitive impairment or dementia\n5. Revision and\u002For Bilateral TKA\n6. Chronic Opioid use",{"count":379,"type":21},50,[65],"Knee replacement surgery is a common and effective treatment for pain and mobility loss, yet up to 1 in 5 patients remain dissatisfied after surgery due to ongoing pain or difficulty with daily activities. Currently, clinicians cannot reliably predict which patients will experience these challenges.\n\nThis study uses MRI scan of the brain to investigate whether specific patterns of brain activity can predict patient satisfaction after total knee arthroplasty (TKA). By comparing brain networks before surgery and afterward, and linking these changes to patient-reported pain and function, we aim to identify brain-based markers that can help predict outcomes, to improve satisfaction after knee replacement surgery.",[383,384,385,27,386],"Knee Osteoarthritis (Knee OA)","Knee Pain Chronic","Brain Network Connectivity","Brain MRI","2026-03-09",{"date":389,"type":42},"2026-03-11",{"date":391,"type":21},"2026-04-01",{"date":393,"type":21},"2028-12-31",{"name":395,"class":49},"Ottawa Hospital Research Institute",{"id":397,"slug":398,"hasResults":12,"nctId":399,"briefTitle":400,"officialTitle":401,"acronym":402,"eligibilityCriteria":403,"healthyVolunteers":58,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":404,"targetDuration":4,"studyType":63,"phases":406,"briefSummary":407,"conditions":408,"keywords":411,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":419,"lastUpdatePostDateStruct":420,"startDateStruct":422,"completionDateStruct":424,"leadSponsor":426,"locationsCount":4},"100624576","peripheral-venous-access-management-by-radiologic-technologists-in-radiodiagnostic-procedure-100624576","NCT07411430","Peripheral Venous Access Management by Radiologic Technologists in Radiodiagnostic Procedure","Peripheral Venous Access Management by Radiologic Technologists in Radiodiagnostic Procedures: Training, Organization, and Patient Safety. Evaluation of a Structured Training Program and Its Clinical and Organizational Effects","TSRM_01","Inclusion Criteria for Radiologic Technologists (RTs):\n\n* Voluntary participation and provision of written informed consent.\n* Completion of the structured theoretical and practical training program for peripheral venous access placement for contrast media administration.\n\nInclusion Criteria for Patients:\n\n* Age ≥18 years\n* Provision of written informed consent.\n* Undergoing a contrast-enhanced CT or MRI examination requiring peripheral venous access placement for contrast media administration.\n\nExclusion Criteria for Radiologic Technologists (RTs):\n\n\\- No written informed consent.\n\nExclusion Criteria for Patients:\n\n* Age \\\u003C18 years.\n* Severe cognitive impairment that precludes valid informed consent or completion of the patient survey.\n* No written informed consent.\n* Clinical conditions that make peripheral venous access placement complex or unsafe, as determined by the clinical team.",{"count":405,"type":21},9,[65],"The goal of this interventional study is to evaluate the impact of a structured training program on the ability of Radiologic Technologists (RTs) to safely and effectively perform peripheral venous access (PVA) placement for contrast media administration in a radiodiagnostic setting.\n\nThe study focuses on adult patients undergoing contrast-enhanced imaging procedures and on Radiologic Technologists who have completed a competency-based theoretical and practical training program on peripheral venous access management.\n\nThe main questions it aims to answer are:\n\n* Does a structured training program improve the theoretical knowledge and technical competencies of Radiologic Technologists in peripheral venous access placement?\n* What is the incidence of complications associated with peripheral venous access placement performed by trained Radiologic Technologists in routine clinical practice?\n* How do patients perceive the procedure in terms of pain, safety, procedural success, and overall satisfaction?\n\nParticipants:\n\n* Radiologic Technologists will participate in a structured theoretical and practical training program focused on peripheral venous access placement for contrast media administration.\n* Radiologic Technologists will perform peripheral venous access placement during routine radiodiagnostic procedures following completion of the training.\n* Patients undergoing contrast-enhanced imaging will receive peripheral venous access placement performed by trained Radiologic Technologists and will complete questionnaires assessing pain, satisfaction, and perceived safety of the procedure.",[409,410,27],"Skill Development of Staff","Clinical Practice",[412,413,414,415,416,417,418],"skills","venipunture","education program","RT's","Radiation Technologists","Nurse","interdisciplinarity","2026-02-11",{"date":421,"type":42},"2026-02-13",{"date":423,"type":21},"2026-02-15",{"date":425,"type":21},"2026-08-15",{"name":427,"class":49},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS",{"id":429,"slug":430,"hasResults":12,"nctId":431,"briefTitle":432,"officialTitle":433,"acronym":4,"eligibilityCriteria":434,"healthyVolunteers":58,"sex":59,"minAge":18,"maxAge":4,"enrollmentInfo":435,"targetDuration":4,"studyType":63,"phases":436,"briefSummary":438,"conditions":439,"keywords":444,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":448,"lastUpdatePostDateStruct":449,"startDateStruct":451,"completionDateStruct":453,"leadSponsor":455,"locationsCount":116},"100622648","phase-4-intrathecal-versus-epidural-morphine-for-post-cesarean-analgesia-100622648","NCT07386353","Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia","Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Pregnant women scheduled for elective cesarean section;\n* Age \\> 18 years;\n* Willingness to participate in the study, as demonstrated by signed informed consent.\n\nExclusion Criteria:\n\n* American Society of Anesthesiologists (ASA) physical status classification \\> III;\n* Chronic kidney disease with a glomerular filtration rate \\\u003C 60 mL\u002Fmin;\n* Relevant drug allergies (particularly to protocol medications);\n* Opioid tolerance;\n* Contraindication to neuraxial anesthetic techniques.",{"count":208,"type":21},[437],"PHASE4","Cesarean section is one of the most commonly performed surgical procedures worldwide, making effective management of acute postoperative pain a key issue in obstetric anesthesiology. Post-cesarean analgesia should promote rapid maternal recovery, support newborn care, and consider the pharmacological implications for breastfeeding.\n\nAccording to recent PROSPECT® guidelines from ESRA, neuraxial opioids play a central role in post-cesarean analgesia and are at least as effective as other techniques, such as continuous local anesthetic infusion. However, the optimal route of opioid administration remains unclear. While earlier studies favored epidural morphine, more recent evidence suggests that intrathecal morphine may provide superior analgesia. Due to limited and conflicting data, no definitive conclusion can be drawn. Given that epidural morphine remains standard practice at Hospital Central do Funchal, a randomized clinical trial is proposed to compare the analgesic efficacy of intrathecal versus epidural morphine after elective cesarean section.",[440,441,442,27,443],"Analgesia Obstetrical","Analgesia","Post Operative Pain","Cesarean Section Pain",[445,446,447],"Post-Cesarean Analgesia","Epidural Morphine","Intrathecal Morphine","2026-01-27",{"date":450,"type":42},"2026-02-04",{"date":452,"type":42},"2024-05-20",{"date":454,"type":21},"2026-07-31",{"name":456,"class":49},"Hospital Central do Funchal",{"id":458,"slug":459,"hasResults":12,"nctId":460,"briefTitle":461,"officialTitle":461,"acronym":4,"eligibilityCriteria":462,"healthyVolunteers":58,"sex":59,"minAge":18,"maxAge":463,"enrollmentInfo":464,"targetDuration":4,"studyType":63,"phases":466,"briefSummary":467,"conditions":468,"keywords":469,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":470,"lastUpdatePostDateStruct":471,"startDateStruct":473,"completionDateStruct":475,"leadSponsor":477,"locationsCount":4},"100617833","effects-of-music-application-and-gum-chewing-on-pain-anxiety-and-patient-satisfaction-during-episiotomy-repair-100617833","NCT07323758","Effects of Music Application and Gum Chewing on Pain, Anxiety, and Patient Satisfaction During Episiotomy Repair","Inclusion Criteria:\n\n* Study participation criteria\n\n  * Women aged 18-49,\n  * Primiparous,\n  * Having a medio-lateral episiotomy,\n  * Having a singleton pregnancy,\n  * Vertex presentation,\n  * Having given birth vaginally,\n  * Having an episiotomy length of 4-5 cm,\n  * Having an uncomplicated newborn,\n  * Volunteering to participate in the study,\n  * Being able to speak and understand Turkish.\n\nExclusion Criteria:\n\n* Women who experienced deep lacerations (anal sphincter injuries, 3rd and 4th degree lacerations) during labor,\n* Those who underwent operative delivery (with vacuum or forceps),\n* Those with visual, hearing, or sensory impairments,\n* Those who were not diagnosed with a psychiatric disorder but had problems,\n* Those diagnosed with a high-risk pregnancy,\n* Those who had any signs of infection, such as vaginal redness or swelling,\n* Those who developed complications during any stage of labor,\n* Women with chronic illnesses (diabetes mellitus, thyroid disease, and hypertension) will not be included in the study.","49 Years",{"count":465,"type":21},60,[65],"Lacerations and episiotomies are serious procedures requiring surgical stitches. Therefore, pain occurs during episiotomy repair. Pain during episiotomy repair also causes anxiety, which in turn exacerbates pain. The goal of pain management is to alleviate pain without experiencing side effects. Midwives and nurses responsible for labor management play an active role in the use of nonpharmacological interventions to manage pain and anxiety during episiotomy repair.\n\nNo studies in the literature have been found that combine music and chewing gum during episiotomy repair. This study aims to determine the effects of music and chewing gum during episiotomy repair on pain, anxiety, and patient satisfaction.\n\nThis study will be to determine the effects of music and chewing gum during episiotomy repair on pain, anxiety, and patient satisfaction.",[97,70,27],[104,75,27],"2026-01-06",{"date":472,"type":42},"2026-01-07",{"date":474,"type":21},"2026-01",{"date":476,"type":21},"2026-05-28",{"name":478,"class":49},"Suleyman Demirel University",{"id":480,"slug":481,"hasResults":12,"nctId":482,"briefTitle":483,"officialTitle":484,"acronym":4,"eligibilityCriteria":485,"healthyVolunteers":58,"sex":17,"minAge":18,"maxAge":60,"enrollmentInfo":486,"targetDuration":4,"studyType":63,"phases":488,"briefSummary":489,"conditions":490,"keywords":491,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":496,"lastUpdatePostDateStruct":497,"startDateStruct":498,"completionDateStruct":500,"leadSponsor":502,"locationsCount":116},"100616893","ultrasound-guided-rsctl-vs-eoip-block-for-analgesia-in-sleeve-gastrectomy-100616893","NCT07311525","Ultrasound-Guided RSCTL vs EOIP Block for Analgesia in Sleeve Gastrectomy","Efficacy of Ultrasound-guided Retro Superior Costotransverse Ligament Space Block Versus External Oblique Intercostal Plane Block for Postoperative Analgesia in Laparoscopic Sleeve Gastrectomy: A Prospective Randomized Study","Inclusion Criteria:\n\n* Patients aged between 18 to 65 years\n* Both genders\n* American Society of Anesthesiologists (ASA) physical status I-II\n* Body mass index (BMI) \\> 40 kg m-2,\n\nExclusion Criteria:\n\n* Obesity secondary to an endocrine disorder\n* known allergic diathesis to any drugs used in the study\n* Presence of serious systemic illness (e.g., severe cardiac, pulmonary, renal, or hepatic dysfunction),\n* Coagulation dysfunction\n* Pre-existing psychological disorders\n* Current use of analgesic or psychotropic medications\n* Infection at a potential injection site\n* Ahistory of chronic pain\n* Conversion to laparotomy.",{"count":487,"type":21},90,[65],"The aim of this study is to compare the effect of ultrasound-guided retro-SCTL space block and EOI block on opioid consumption within 24 hours after LSG.",[27],[492,493,494,495],"Sleeve Gastrectomy","Postoperative Analgesia","External Oblique Intercostal Plane Block","Retro superior costotransverse ligament space block","2026-01-01",{"date":470,"type":42},{"date":499,"type":21},"2026-02-01",{"date":501,"type":21},"2027-02-01",{"name":503,"class":49},"Beni-Suef University",{"id":505,"slug":506,"hasResults":12,"nctId":507,"briefTitle":508,"officialTitle":508,"acronym":509,"eligibilityCriteria":510,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":511,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":512,"conditions":513,"keywords":521,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":524,"lastUpdatePostDateStruct":525,"startDateStruct":527,"completionDateStruct":529,"leadSponsor":531,"locationsCount":250},"100617117","procedural-sedation-and-analgesia-for-treatment-of-adults-with-fractures-and-dislocations-in-the-emergency-department-100617117","NCT07314450","Procedural Sedation and Analgesia for Treatment of Adults With Fractures and Dislocations in the Emergency Department","PAINEX","Inclusion Criteria:\n\n1. Age ≥18.\n2. Patients with the following injuries are eligible:\n\n   1. Reduction treatment of shoulder dislocation\n   2. Reduction treatment of elbow dislocation\n   3. Reduction treatment of distal radius fractures, application of cast\n   4. Reduction treatment of finger fractures\u002Fdislocation\n   5. Casting treatment of upper extremity fractures\n\n      * Proximal humerus fracture, application of fixed sling\n      * Humeral shaft fracture, application of Sarmiento brace\n      * Supracondylar fracture, application of angled cast\n   6. Reduction treatment of hip dislocation\n   7. Reduction treatment of patella dislocation\n   8. Reduction of tibial shaft fracture, application of cast\n   9. Reduction treatment of ankle fractures including distal tibia fracture\n   10. Reduction treatment for toe fractures\u002Fdislocation\n   11. Casting treatment of lower extremity fractures\n\n       * Distal femur fracture, application of cast\u002Ftraction\n       * Proximal tibia fracture, application of cast or hinged brace\n       * Ankle fracture, application of walker\n\nExclusion Criteria:\n\n1. Unable to give informed consent (e.g. unconscious, psychotic or dementia)\n2. Unwilling to participate in the study\n3. Prior inclusion in the study\n4. Already included in another clinical study at the same day\u002Fhospital visit\n5. Pregnant or breastfeeding",{"count":20,"type":21},"The goal of this observational study is to evaluate the effectiveness and safety of different procedural sedation and analgesia methods used for adults with painful fractures requiring reduction treatment in the emergency department.\n\nThe main questions it aims to answer are:\n\n* Which sedation and analgesia methods provide the best patient satisfaction and pain relief?\n* How do different treatment methods affect clinician satisfaction and the occurrence of adverse events?\n\nThe investigators will compare different types of procedural sedative and analgesic treatments (such as systemic sedation\u002Fanalgesia and regional techniques like nerve or hematoma blocks) to see which approach offers the best patient satisfaction and most effective pain control.\n\nParticipants will:\n\nBe adult patients with upper or lower extremity fractures or joint dislocations requiring painful reduction procedures.\n\nReceive one of the routinely used sedation or analgesia treatments (or no analgesia) during their emergency department care.\n\nReport their pain levels and satisfaction before, during, and after treatment. Be monitored for any side effects, complications, or use of antidotes. Data will be collected over a six-month period at Odense University Hospital, Holbæk Hospital, and Zealand University Hospital, Køge, following the STROBE guidelines for observational studies.",[514,441,515,27,516,160,517,518,519,520],"Pain, Procedural","Extremity Injury","Satisfaction, Personal","Upper Extremity Injury","Lower Extremity Fracture","Upper Extremity Fracture","Extremity Injuries Lower",[522,523],"Emergency Department","Procedural sedation and analgesia","2025-12-17",{"date":526,"type":42},"2026-01-02",{"date":528,"type":42},"2025-07-29",{"date":530,"type":21},"2026-07-01",{"name":532,"class":49},"Region Zealand",{"id":534,"slug":535,"hasResults":12,"nctId":536,"briefTitle":537,"officialTitle":538,"acronym":4,"eligibilityCriteria":539,"healthyVolunteers":12,"sex":59,"minAge":18,"maxAge":4,"enrollmentInfo":540,"targetDuration":4,"studyType":63,"phases":541,"briefSummary":542,"conditions":543,"keywords":545,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":553,"lastUpdatePostDateStruct":554,"startDateStruct":556,"completionDateStruct":558,"leadSponsor":560,"locationsCount":50},"100616915","pain-management-for-in-office-gynecologic-procedures-using-a-risk-stratification-pain-calculator-100616915","NCT07311824","Pain Management for In-Office Gynecologic Procedures Using a Risk-Stratification Pain Calculator","Pain Management Optimization for In-Office Gynecologic Procedures: The Development and Evaluation of a Risk-Stratification Pain Calculator","Inclusion Criteria:\n\n* At least 18 years of age\n* Proficient in English\n* Access to personal smart devices (smartphone, tablet, laptop, etc.)\n* Will be undergoing the following in-office gynecologic procedures: IUD insertion, endometrial biopsy, colposcopy with cervical biopsy, or hysteroscopy\n\nExclusion Criteria:\n\n* Under the age of 18\n* Non-English-Speaking\n* Have contraindications to taking NSAIDs, acetaminophen, lidocaine or its derivatives, or opioids\n* Patients who are taking methadone, Suboxone, and\u002For naltrexone",{"count":20,"type":21},[65],"The goal of this clinical trial is to learn how using a risk-stratification calculator to determine the risk of a patient experiencing severe pain during an in-office gynecologic procedure and subsequently assigning pain medications to be used for the procedure based on risk, will affect patients' pain during these procedures. The main questions it aims to answer are:\n\n* Does using pain medications determined by a risk-stratification calculator improve patients' pain scores during if-office gynecologic procedures?\n* Does using pain medications determined by a risk-stratification calculator improve patient satisfaction?\n\nResearchers will compare using the risk-stratification calculator to decide on pain medications to a provider using their best judgement to decide on pain medications. This will help determine if patients have improved pain scores and satisfaction if they have their pain medications assigned using the risk-stratification calculator.\n\nParticipants who are undergoing a relevant in-office gynecologic procedure will:\n\n* Receive pain medications for their procedure either based on their answers to questions for the risk-stratification calculator or based on their provider's best judgement.\n* Answer an online survey about their experience with the procedure and related pain management.",[216,27,544],"Gynecologic Procedures",[546,74,547,548,549,550,551,552],"pain management","gynecologic procedures","IUD insertion","hysteroscopy","endometrial biopsy","colposcopy","ambulatory gynecologic procedures","2025-12-16",{"date":555,"type":42},"2025-12-31",{"date":557,"type":21},"2025-12-29",{"date":559,"type":21},"2027-04-30",{"name":561,"class":49},"Carle Foundation Hospital",{"id":563,"slug":564,"hasResults":12,"nctId":565,"briefTitle":566,"officialTitle":566,"acronym":4,"eligibilityCriteria":567,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":568,"targetDuration":569,"studyType":22,"phases":4,"briefSummary":570,"conditions":571,"keywords":574,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":578,"lastUpdatePostDateStruct":579,"startDateStruct":581,"completionDateStruct":583,"leadSponsor":585,"locationsCount":116},"100614013","hospital-at-home-versus-inpatient-care-costs-and-effectiveness-100614013","NCT07274072","Hospital at Home Versus Inpatient Care: Costs and Effectiveness","Inclusion Criteria:\n\n* Inpatients in the hospital or patients in Hospital at Home care\n* Age ≥ 18 years\n* Admission due to a typical Hospital at Home diagnosis (mild to moderate inflammatory and infectious diseases of the lungs, urinary tract, gastrointestinal tract, heart, and skin; exacerbated chronic obstructive pulmonary disease; exacerbation of chronic heart failure; wounds; bleeding\u002Fanemia; dehydration; deterioration of general condition in multimorbid patients; infection-related complications in oncological patients; psychiatric problems including delirium; metabolic or autoimmune diseases; orthopedic patients; pain exacerbations of any cause; palliative patients up to and including terminal situations)\n* Patients without severe cognitive impairment or dysfunction who are capable of providing informed consent and\u002For completing the questionnaire\n* Patients with sufficient proficiency in written and spoken German and\u002For English\n\nExclusion Criteria:\n\n* Inpatient admission for other reasons\n* Refusal to provide informed consent",{"count":20,"type":21},"1 Day","Background and Objectives Hospital at Home (HaH) delivers hospital-level treatment to acutely ill patients in their own homes, including daily medical and nursing visits, infusions, physiotherapy, and diagnostics. It bridges inpatient and outpatient care, working closely with hospitals, office-based physicians, home care services (Spitex), and therapy providers.\n\nThere are two main pathways:\n\nAdmission Avoidance: stable patients requiring hospitalization are admitted directly to HaH instead of an inpatient ward.\n\nEarly Supported Discharge: patients treated in hospital are discharged earlier than usual and transferred to HaH.\n\nEvidence International studies show HaH to be safe and effective. Reviews report comparable mortality and rehospitalization, shorter hospital stays, and cost advantages. Admission avoidance is linked to trends toward lower mortality and costs. Research showed similar mortality but fewer rehospitalizations, longer treatment duration, and reduced risks of institutionalization, depression, and anxiety. HaH patients were older, with reduced daily living activities, yet care costs were on average USD 5,054 lower than inpatient care.\n\nIn Switzerland, the mean hospital stay in 2019 was 8 days (acute somatic: 5.2; psychiatry: 33.5).\n\nStudy Hypotheses\n\nHaH can be delivered at equal or lower cost than regular hospitalization.\n\nHaH care is safe, with few complications, and yields high patient satisfaction.\n\nStudy Objective To demonstrate that hospital-equivalent home treatment of acutely ill patients is effective, appropriate, cost-efficient (according to Swiss WZW criteria), safe, and associated with high satisfaction and low complication rates compared with inpatient care.\n\nEndpoints\n\nPrimary: Costs - HaH vs. inpatient care at Hirslanden Clinic, using REKOLE® cost accounting.\n\nSecondary: Mortality, therapy type, monitoring, diagnostics, rehospitalization, complications, satisfaction, patient-reported outcomes, length of stay, referrals to nursing homes, follow-up after discharge, ED visits, rehabilitation referrals, and home care type.",[572,573,27],"Costs and Cost Analysis","Effectiveness",[575,576,577,74],"hospital at home","costs","clinical outcome","2025-12-09",{"date":580,"type":42},"2025-12-10",{"date":582,"type":42},"2025-09-01",{"date":584,"type":21},"2026-08-31",{"name":586,"class":587},"Hospital at Home AG","INDUSTRY",{"id":589,"slug":590,"hasResults":12,"nctId":591,"briefTitle":592,"officialTitle":593,"acronym":4,"eligibilityCriteria":594,"healthyVolunteers":12,"sex":59,"minAge":18,"maxAge":4,"enrollmentInfo":595,"targetDuration":4,"studyType":63,"phases":596,"briefSummary":597,"conditions":598,"keywords":600,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":606,"lastUpdatePostDateStruct":607,"startDateStruct":608,"completionDateStruct":610,"leadSponsor":612,"locationsCount":116},"100551375","feasibility-of-calm-in-patients-with-ovarian-cancer-100551375","NCT06459271","Feasibility of CALM in Patients With Ovarian Cancer","A Feasibility Trial of Managing Cancer and Living Meaningfully (CALM) in Patients With Newly Diagnosed and Recurrent Advanced Ovarian Cancer","Inclusion Criteria:\n\n* new diagnosis or recurrence of stage III or stage IV OC;\n* age ≥18 years\n* able to complete outcome measures and engage in CALM in English.\n\nExclusion Criteria:\n\n* evidence of cognitive impairment indicated in the medical record, communicated by the OC clinic team, or determined by research staff at recruitment;\n* receiving psychological or psychiatric counseling from the Department of Supportive Care at PM at the time of recruitment.",{"count":379,"type":21},[65],"The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC).\n\nThe main questions are:\n\n1. Is it feasible and acceptable to implement CALM for patients with newly diagnosed or recently recurred advanced OC\n2. What are the prevalence and correlates of traumatic stress symptoms at baseline in patients with newly diagnosed or recently recurred advanced OC\n\nParticipants will be asked to complete questionnaires at baseline and at 3 and 6 months following a diagnosis or recurrence of stage III or IV OC. Participants will also be invited to participate in 3-6 sessions of CALM therapy.",[27,599],"Ovarian Cancer",[601,602,603,604,605],"ovarian cancer","psychological care","CALM","psychotherapeutic intervention","psychological distress","2025-12-08",{"date":553,"type":42},{"date":609,"type":42},"2024-06-10",{"date":611,"type":21},"2026-08-10",{"name":613,"class":49},"University Health Network, Toronto",{"id":615,"slug":616,"hasResults":12,"nctId":617,"briefTitle":618,"officialTitle":619,"acronym":4,"eligibilityCriteria":620,"healthyVolunteers":58,"sex":59,"minAge":4,"maxAge":4,"enrollmentInfo":621,"targetDuration":4,"studyType":63,"phases":623,"briefSummary":624,"conditions":625,"keywords":627,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":632,"lastUpdatePostDateStruct":633,"startDateStruct":635,"completionDateStruct":637,"leadSponsor":638,"locationsCount":116},"100612054","empathy-training-and-its-effect-on-maternity-nurses-communication-skills-100612054","NCT07248592","Empathy Training and Its Effect on Maternity Nurses' Communication Skills","Empathy Training: Its Effect on Maternity Nurses' Communication and Parturient Women's Perception of Empathetic Care","Inclusion Criteria:\n\n* Be currently employed in a maternity care setting Labor \\& Delivery Unit.\n* Have direct patient contact with parturient women as a primary part of their regular duties.\n* Have a minimum of 6 months of experience.\n\nExclusion Criteria:\n\n* Nurses whose primary role is administrative, managerial without direct patient care responsibilities.\n* Have previously participated in a pilot or feasibility study for the same or a highly similar intervention.\n* Planned absence (e.g., extended leave, vacation) for a significant portion of the study intervention or data collection period.",{"count":622,"type":21},45,[65],"The goal of this clinical trial is to evaluate the effectiveness of empathy skills training on Maternity Nurses' Communication and Parturient Women's Perception of Empathetic Care.\n\nThe main questions it aims to answer are;\n\n* Do maternity nurses who received empathy skills training have better empathetic communication skills when caring with parturient women than those who don't.?\n* Do parturient women who received care from maternity nurses trained with empathy skills training perceive higher empathy level than mothers who received care from untrained nurses?\n\nParticipants will:\n\n* Have 3 educational training sessions on empathy communication skills.\n* Will be followed by the researcher for any clarifications about the educational content of session\n* nurses will be asked to evaluate their empathy communication skills twice (once before training and second time after training) .\n\nalso parturient women will be asked to assess their maternity nurses' empathy care level twice (once before training and second time after training).",[626,27],"Communication Skills",[628,629,630,631],"Maternity nurses","empathetic communication skills","women perception","Parturient women","2025-11-18",{"date":634,"type":42},"2025-11-25",{"date":636,"type":21},"2025-12-15",{"date":247,"type":21},{"name":639,"class":49},"Mansoura University",{"id":641,"slug":642,"hasResults":12,"nctId":643,"briefTitle":644,"officialTitle":645,"acronym":4,"eligibilityCriteria":646,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":647,"targetDuration":4,"studyType":63,"phases":649,"briefSummary":650,"conditions":651,"keywords":4,"overallStatus":106,"whyStopped":4,"lastUpdateSubmitDate":656,"lastUpdatePostDateStruct":657,"startDateStruct":659,"completionDateStruct":661,"leadSponsor":663,"locationsCount":116},"100602514","regional-anesthesia-in-tka-impact-on-postoperative-joint-motion-and-patient-satisfaction-100602514","NCT07124494","Regional Anesthesia in TKA: Impact on Postoperative Joint Motion and Patient Satisfaction","Evaluation of the Effects of Regional Anesthesia Methods Applied in Total Knee Arthroplasty on Joint Range of Motion in the Postoperative Period and Patient Satisfaction","* Minimum Age: 18 Years\n* Maximum Age: None\n* Sex: All\n* Gender Based: No\n* Accepts Healthy Volunteers: No\n* Inclusion Criteria:\n\n  * Scheduled for primary total knee arthroplasty\n  * Age ≥ 18 years\n  * American Society of Anesthesiologists (ASA) physical status I-III\n  * Accepting neuraxial anesthesia\n* Exclusion Criteria:\n\n  * Skin infection at the planned injection site\n  * Sepsis\n  * Coagulopathy\n  * Refusal of neuraxial anesthesia\n  * Severe hypovolemia\n  * Demyelinating central nervous system disease\n  * Age under 18 years\n  * Illiterate in Turkish\n  * Non-cooperative patients\n  * Known allergy or hypersensitivity to bupivacaine",{"count":648,"type":21},30,[65],"This is a single-center, prospective, randomized controlled trial aiming to evaluate the effects of different regional anesthesia\u002Fanalgesia techniques on postoperative knee range of motion (ROM) and patient satisfaction following total knee arthroplasty (TKA). Ninety patients undergoing elective TKA under spinal anesthesia will be randomly assigned to one of three groups: 1) spinal anesthesia with epidural catheter, 2) spinal anesthesia followed by adductor canal catheterization, and 3) spinal anesthesia with multimodal intravenous analgesia. The primary outcome is postoperative knee joint ROM measured on postoperative days 1, 2, and 3. Secondary outcomes include patient satisfaction, Oxford Knee Score, postoperative opioid consumption, and VAS scores. The study is conducted at Konya City Hospital and will be completed over a 6-month period.",[652,653,654,655,27],"Total Knee Arthroplasty","Postoperative Pain","Regional Anesthesia","Knee Range of Motion","2025-08-21",{"date":658,"type":42},"2025-08-28",{"date":660,"type":42},"2025-08-05",{"date":662,"type":21},"2026-02-19",{"name":664,"class":49},"Konya City Hospital",{"id":666,"slug":667,"hasResults":12,"nctId":668,"briefTitle":669,"officialTitle":670,"acronym":4,"eligibilityCriteria":671,"healthyVolunteers":58,"sex":17,"minAge":18,"maxAge":672,"enrollmentInfo":673,"targetDuration":4,"studyType":63,"phases":674,"briefSummary":675,"conditions":676,"keywords":677,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":679,"lastUpdatePostDateStruct":680,"startDateStruct":682,"completionDateStruct":684,"leadSponsor":685,"locationsCount":116},"100600683","this-study-will-assess-whether-the-treatment-provided-by-dentist-is-successful-in-meeting-the-expectations-of-patient-by-asking-questions-related-to-aesthetics-chewing-ability-comfort-and-phonetics-before-and-after-providing-treatment-and-the-patient-will-tell-through-visual-analog-scale-100600683","NCT07100678","This Study Will Assess Whether the Treatment Provided by Dentist is Successful in Meeting the Expectations of Patient by Asking Questions Related to Aesthetics, Chewing Ability, Comfort and Phonetics Before and After Providing Treatment and the Patient Will Tell Through Visual Analog Scale","Comparison Of Pretreatment Expectations and Posttreatment Satisfaction In Patients Receiving Porcelain-Fused-to-Metal Fixed Dental Prosthesis: A Quasi-Experimental Study","Inclusion Criteria:\n\n* Partially edentulous subjects between age group of 18 to 60 years.\n* Patients who require and are willing to receive a fixed dental prosthesis.\n* Patients with no experience of Fixed dental prosthesis previously.\n\nExclusion Criteria:\n\n* Patients diagnosed with any psychological disorders (diagnosed by physician).\n* Patients with facial anomalies like cleft lip and palate.\n* Patients with skeletal class 2 or class 3.\n* Patients with facial paralysis, stroke, and speech disorders.","60 Years",{"count":208,"type":21},[65],"This study aims to assess patient satisfaction after receiving porcelain-fused-to-metal fixed dental prostheses. Patients will be asked about their expectations before treatment and their satisfaction afterward. The findings will help evaluate whether the treatment meets patient needs and guide improvements in dental care.",[27],[678],"patient satisfaction PFM Prosthodontics","2025-08-02",{"date":681,"type":42},"2025-08-07",{"date":683,"type":21},"2025-10-01",{"date":301,"type":21},{"name":686,"class":49},"Khyber College of dentistry",{"id":688,"slug":689,"hasResults":12,"nctId":690,"briefTitle":691,"officialTitle":691,"acronym":692,"eligibilityCriteria":693,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":694,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":696,"conditions":697,"keywords":700,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":703,"lastUpdatePostDateStruct":704,"startDateStruct":706,"completionDateStruct":707,"leadSponsor":709,"locationsCount":116},"100594462","experience-with-the-use-of-continuous-glucose-monitoring-cgm-devices-in-people-with-type-2-diabetes-mellitus-100594462","NCT07019753","Experience With the Use of Continuous Glucose Monitoring (CGM) Devices in People With Type 2 Diabetes Mellitus","Glucocavi","Inclusion Criteria:\n\n* Have been using a CGM sensor daily for diabetes management for the past 12 months or more.\n* Treatment with intensive insulin therapy (basal bolus regimen with 3 or more daily doses of insulin).\n* Agree to participate in the study.\n\nExclusion Criteria:\n\n* Cognitive impairment measured by the SPMSQ test with a score of 3 or more errors.\n* Being institutionalised.\n* Have another person responsible for monitoring the device and making decisions related to diabetes (insulin adjustment, carbohydrate rations, etc.).\n* Language difficulty: not being able to hold a fluent conversation in Catalan or Spanish for 30-60 minutes.",{"count":695,"type":21},5,"Background: In recent years, diabetes management has evolved with the introduction of continuous glucose monitoring (CGM) devices. Some qualitative studies have been conducted to assess the experiences of patients with type 2 diabetes mellitus (T2DM) using CGM devices, but none have been conducted in a Mediterranean country. Furthermore, there are differences in the amount of time study participants used the CGM device, ranging from 14 days to 6 months, and in some studies, participants did not receive insulin treatment.\n\nObjectives: To understand the benefits and barriers described by people with type 2 diabetes mellitus who use CGM devices through inductive thematic analysis of interviews conducted with them.\n\nMethodology: Qualitative study with a phenomenological approach and conversational technique. Adults with T2DM who have used a CGM device continuously for the past 12 months will be interviewed individually.\n\nData analysis: They will be analyzed using inductive thematic analysis. The interviews will be transcribed verbatim, along with any relevant data collected by the other researcher present at the interview. Three researchers will then conduct a preliminary analysis, from which codes will be agreed upon and themes, categories, and subcategories will be proposed through triangulation among the researchers. This will be done inductively, through analysis, in-depth reflection, and debate among the three researchers.\n\nApplicability and relevance: Knowing the opinion of people with T2DM who use CGM devices, as well as the barriers and facilitators they find to its use will help healthcare professionals to better understand their patients and thus provide more personalised and closer healthcare. In addition, healthcare managers and administrators will be able to find out whether patients find it useful to use a CGM device, whether they reduce the use of capillary glycaemia strips, whether they become more aware of their disease and increase their self-monitoring, etc. All this will help to decide whether it is beneficial to extend the indication of these devices to more people with type 2 diabetes.",[27,698,699],"Continuous Glucose Monitoring","Type 2 Diabetes Mellitus (T2DM)",[698,27,699,701,702],"Quality of Life","Primary Care","2025-07-04",{"date":705,"type":42},"2025-07-09",{"date":474,"type":21},{"date":708,"type":21},"2026-10-31",{"name":710,"class":49},"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina"]